Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis

Area of Science:

• Biochemistry
• Neuroscience
• Medical Diagnostics

Background:

• Metabolomics offers a powerful approach for discovering sensitive disease biomarkers.
• Multiple Sclerosis (MS) is a chronic neurological disease with complex pathogenesis.
• Cerebrospinal fluid (CSF) is a critical biofluid for studying central nervous system disorders.

Purpose of the Study:

• To identify novel cerebrospinal fluid (CSF) biomarkers for multiple sclerosis (MS) using high-resolution metabolomics.
• To investigate metabolic alterations associated with MS pathogenesis.
• To assess the diagnostic potential of CSF metabolite profiles in distinguishing MS patients from healthy controls.

Main Methods:

• High-field (800 MHz) 1H-nuclear magnetic resonance (NMR) spectroscopy was employed for CSF metabolomic profiling.
• Quantitative analysis of 15 distinct metabolites was performed.
• Multivariate statistical analyses, including hierarchal cluster analysis and principal components analysis (PCA), were utilized to analyze metabolite data.

Main Results:

• Significant differences in metabolite levels were observed between MS patients and non-MS controls (p<0.05).
• Increased levels of choline, myo-inositol, and threonate were detected in MS CSF.
• Decreased levels of 3-hydroxybutyrate, citrate, phenylalanine, 2-hydroxyisovalerate, and mannose were found in MS CSF, indicating altered energy and phospholipid metabolism.
• Metabolite profiles successfully clustered samples into distinct MS and non-MS groups via multivariate analysis.

Conclusions:

• CSF metabolomics can identify quantitative biomarkers for multiple sclerosis (MS).
• The observed metabolic alterations provide insights into the underlying pathogenesis of MS.
• This approach holds promise for improving MS diagnosis and understanding disease mechanisms.